Latest News - Galderma

Friday, February 23, 2018

Galderma Enters into Long-term Research Agreement on AD with Icahn School of Medicine at Mount Sinai and Northwestern University Feinberg School of Medicine

Galderma has signed a joint research agreement on Atopic Dermatitis (AD) with two leading academic institutions -- Icahn School of Medicine at Mount Sinai in New York City, and Northwestern University…

Read the full story

Thursday, October 12, 2017

FDA Approves Injection of Restylane Silk via Cannula for Lip Augmentation

The FDA has approved the use of a small blunt tip cannula with Galderma's Restylane Silk for lip augmentation. Restylane Silk was the first FDA-approved hyaluronic acid (HA) dermal filler specific…

Read the full story

Friday, September 15, 2017

Happy 70th Cetaphil!

Cetaphil is turning 70! To celebrate this milestone birthday, which takes place on Sept. 19, Cetaphil will launch a series of initiatives including: A 70-hour flash sale across retail partner…

Read the full story

Monday, September 11, 2017

Two Galderma Rosacea Therapies Work Well Together

Combined use of Galderma’s SOOLANTRA (ivermectin1% Cream) and Mirvaso (Brimonidine 0.33% Gel) pack a one-two punch against the erythema and inflammatory lesions of rosacea, the MirvasO Soolantra…

Read the full story

Thursday, September 07, 2017

Galderma Names New Managers of Prescription Business and Aesthetic & Corrective Business Units; Dr. Kelly Huang to Obalon

Galdmera has named new managers of its Prescription Business and Aesthetic & Corrective Business units in the United States. Chris Chapman is Galderma’s new Vice President and General Manage…

Read the full story

Monday, July 17, 2017

Galderma CareConnect Patient Savings Card Program Passes Milestone

The Galderma CareConnect patient savings program has surpassed the mark of 1,000,000 prescriptions filled through its patient access program. Committed to keeping accessibility remarkably simple and s…

Read the full story

Monday, July 17, 2017

Patent Challenge Filed for Generic Version Of Soolantra Cream

Perrigo Company plc's subsidiary has filed a Paragraph IV Abbreviated New Drug Application with the FDA for a generic version of Soolantra® (ivermectin) cream, 1%. Following notification fr…

Read the full story

Wednesday, July 05, 2017

Study: Soolantra is Both Anti-Inflammatory and Anti-Demodex

A recently published study sought to find scientific rationale for the dual anti-inflammatory and anti-parasitic mode of action of topical ivermectin 1% cream (Soolantra) in patients with rosacea. …

Read the full story

Thursday, April 06, 2017

Phase 4 Studies of Restylane® Refyne and Restylane® Defyne Show Lasting Natural Benefit

Two Phase 4 clinical studies of Restylane® Refyne and Restylane® Defyne show that the natural-looking results last. Specifically, the Natural Expression study found that…

Read the full story

Thursday, March 02, 2017

Galderma Moves to Differentiate Their Two New HA Fillers From The Fray

With a growing number of hyaluronic acid (HA) fillers available and even more in the pike, Galderma is highlighting how their two newest fillers --Restylane Refyne and Restylane Defyne  --stand o…

Read the full story

Thursday, March 02, 2017

Modernizing Medicine and Galderma Team Up to Offer Integrated OTC eCommerce Platform

Specialty-specific health information technology company Modernizing Medicine, Inc. and Galderma Laboratories, L.P. are collaborating to deliver new capabilities in support of improved patient experie…

Read the full story

Thursday, March 02, 2017

Galderma and Colorescience Launch Collaboration

Galderma will collaborate with Colorescience to expand skincare solutions to individuals who seek innovative daily skincare products that can be used in conjunction with traditional facial injectable …

Read the full story

Thursday, February 02, 2017

Galderma’s OTC Differin Gel Hits Store Shelves

Galderma’s Differin Gel 0.1% (adapalene) is now available over the counter (OTC) at major retail and drug stores. Galderma officially launched the gel at a New York City media fete, and …

Read the full story

Monday, December 12, 2016

Galderma's Restylane Refyne and Restylane Defyne Fillers FDA Approved for “Laugh Lines”

The FDA  approved two new products for the treatment of nasolabial folds (NLF) or “laugh lines,” in patients over the age of 21 -- Galderma's Restylane Refyne and Restylane Defyne…

Read the full story

Monday, August 29, 2016

Cetaphil® Marks Fifth Year of Support for CSDF and Camp Wonder

Galderma Laboratories, L.P., makers of Cetaphil, is celebrating the fifth consecutive year of its "Meaningphil™" partnership with the Children's Skin Disease Foundation (…

Read the full story
Load More